New cancer drug enters early human testing for advanced solid tumors
NCT ID NCT07438782
First seen Jun 27, 2026 · Last updated Jul 22, 2026 · Updated 2 times
Summary
This early-phase study tests a new drug called GSK5533524, alone or with other cancer treatments, in adults with advanced solid tumors that have stopped responding to standard therapies. The main goals are to find a safe dose and see if the drug can shrink tumors or slow cancer growth. About 97 participants will take part to help researchers decide the best dose for future studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
GSK Investigational Site
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
-
GSK Investigational Site
RECRUITINGSan Antonio, Texas, 78229, United States
-
GSK Investigational Site
RECRUITINGToronto, Ontario, M5G 2M9, Canada
-
GSK Investigational Site
RECRUITINGMontreal, Quebec, H2X 0A9, Canada
-
GSK Investigational Site
RECRUITINGMontreal, Quebec, H3T 1E2, Canada
-
GSK Investigational Site
RECRUITINGHelsinki, 00029, Finland
-
GSK Investigational Site
RECRUITINGSaitama, 350-1298, Japan
-
GSK Investigational Site
RECRUITINGShizuoka, 411-8777, Japan
-
GSK Investigational Site
RECRUITINGTokyo, 104-0045, Japan
-
GSK Investigational Site
RECRUITINGTokyo, 135-8550, Japan
-
GSK Investigational Site
RECRUITINGBarcelona, 08035, Spain
-
GSK Investigational Site
RECRUITINGMadrid, 28009, Spain
-
GSK Investigational Site
RECRUITINGMadrid, 28027, Spain
-
GSK Investigational Site
RECRUITINGMadrid, 28041, Spain
-
GSK Investigational Site
RECRUITINGMadrid, 28050, Spain
-
GSK Investigational Site
RECRUITINGCambridge, CB2 2QQ, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple screening program could transform cancer aftercare
- A new program aims to ease the 'Lost in Transition' struggle for cancer survivors
- Can a new immune drug outsmart Hard-to-Treat tumors?
- Can a simple text message transform cancer care?
- Can modern Radiotherapy's late effects be predicted?
- One drop, many cancers? a rapid test aims to spot cancer signals in blood, urine, or saliva